RVLP - RVL Pharmaceuticals plc GAAP EPS of -$0.12 in-line revenue of $8.83M misses by $0.37M
2023-05-11 06:51:57 ET
- RVL Pharmaceuticals plc press release ( NASDAQ: RVLP ): Q1 GAAP EPS of -$0.12 in-line.
- Revenue of $8.83M (-58.7% Y/Y) misses by $0.37M .
For further details see:
RVL Pharmaceuticals plc GAAP EPS of -$0.12 in-line, revenue of $8.83M misses by $0.37M